301225 Product Name: Midazolam, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout, in het bijzonder Midazolam HCl, geformuleerd in combinatie met ethanol
Filing date | Document type | Document Description | Number of pages | File Type | ||
---|---|---|---|---|---|---|
26/04/2024 | SPC Documents | Annex SPC | 16 | /6/1/6/6/6/0800866616/docs/301225_13_supplprotectioncertificate20240426011818461.pdf | ||
26/04/2024 | SPC Documents | Annex SPC | 7 | /6/1/6/6/6/0800866616/docs/301225_14_supplprotectioncertificate20240426011743814.pdf | ||
26/04/2024 | SPC Documents | Annex SPC | 14 | /6/1/6/6/6/0800866616/docs/301225_15_supplprotectioncertificate20240426011850568.pdf | ||
26/04/2024 | SPC Documents | Annex SPC | 19 | /6/1/6/6/6/0800866616/docs/301225_16_supplprotectioncertificate20240426012000797.pdf | ||
26/04/2024 | SPC Documents | Annex SPC | 9 | /6/1/6/6/6/0800866616/docs/301225_17_supplprotectioncertificate20240426011923302.pdf | ||
26/04/2024 | SPC Documents | Annex SPC | 11 | /6/1/6/6/6/0800866616/docs/301225_18_supplprotectioncertificate20240426012040369.pdf | ||
26/04/2024 | SPC Documents | Accompanying letter SPC | 12 | /6/1/6/6/6/0800866616/docs/301225_19_supplprotectioncertificate20240426012324476.pdf | ||
12/02/2024 | Outgoing Correspondence | Letter to applicant | 1 | /6/1/6/6/6/0800866616/docs/301225_3_591218l173.pdf | ||
08/02/2024 | Incoming Correspondence Paper | Accompanying letter incoming document | 1 | /6/1/6/6/6/0800866616/docs/301225_2_incomingcorrespondencepaper20240208024414561.pdf | ||
23/10/2023 | Incoming Correspondence Electronic | Accompanying letter incoming document | 1 | /6/1/6/6/6/0800866616/docs/301225_0_incomingcorrespondenceelectronic20231023033255913.pdf | ||
23/10/2023 | Outgoing Correspondence | Letter to applicant | 1 | /6/1/6/6/6/0800866616/docs/301225_1_572584l173.pdf | ||
26/07/2023 | Outgoing Correspondence | Letter to applicant | 4 | /6/1/6/6/6/0800866616/docs/301225_12_556417l173.pdf | ||
11/04/2023 | SPC Documents | Accompanying letter SPC | 1 | /6/1/6/6/6/0800866616/docs/301225_4_supplprotectioncertificate20230411023409522.pdf | ||
11/04/2023 | SPC Documents | Marketing Authorization SPC | 1 | /6/1/6/6/6/0800866616/docs/301225_5_supplprotectioncertificate20230411024137730.pdf | ||
11/04/2023 | Application Form | First filed application form | 2 | /6/1/6/6/6/0800866616/docs/301225_6_applicationform20230411030920470.pdf | ||
11/04/2023 | SPC Documents | Summary of the characteristics of the product | 19 | /6/1/6/6/6/0800866616/docs/301225_7_supplprotectioncertificate20230411023801634.pdf | ||
11/04/2023 | SPC Documents | Marketing Authorization SPC | 1 | /6/1/6/6/6/0800866616/docs/301225_8_supplprotectioncertificate20230411024045100.pdf | ||
11/04/2023 | SPC Documents | SPC Documents | 2 | /6/1/6/6/6/0800866616/docs/301225_9_supplprotectioncertificate20230411023322830.pdf | ||
11/04/2023 | SPC Documents | SPC Documents | 1 | /6/1/6/6/6/0800866616/docs/301225_10_supplprotectioncertificate20230411023954676.pdf | ||
11/04/2023 | Outgoing Correspondence | Confirmation receipt request | 1 | /6/1/6/6/6/0800866616/docs/301225_11_540592l174.pdf |